CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 460574869
- Phone
- (857) 284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-01 | Sommadossi Jean-Pierre President, CEO, and Chairman | Sale 10b5-1 | −56,910 | $3.85 | $219K | 116,557 |
| 2024-02-01 | Horga Maria Arantxa Chief Medical Officer | Sale | −15,870 | $3.84 | $61K | 25,664 |
| 2024-02-01 | Foster Wayne EVP, Chief Accounting Officer | Sale | −12,477 | $3.84 | $48K | 20,857 |
| 2024-02-01 | Vavricka John Chief Commercial Officer | Sale | −11,819 | $3.84 | $45K | 21,515 |
| 2024-02-01 | Hammond Janet MJ Chief Development Officer | Sale | −14,029 | $3.84 | $54K | 35,362 |
| 2024-01-31 | Corcoran Andrea See Remarks | Option exercise | +44,367 | 686,051 | ||
| 2024-01-31 | Corcoran Andrea See Remarks | Option exercise · Restricted Stock Units | −44,367 | 88,733 | ||
| 2024-01-31 | Corcoran Andrea See Remarks | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2024-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Option exercise 10b5-1 | +173,467 | 173,467 | ||
| 2024-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Option exercise · Restricted Stock Units 10b5-1 | −173,467 | 346,933 | ||
| 2024-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Grant or award · Stock Option (Right to Buy) 10b5-1 | +448,000 | 448,000 | ||
| 2024-01-31 | Horga Maria Arantxa Chief Medical Officer | Option exercise | +41,534 | 41,534 | ||
| 2024-01-31 | Horga Maria Arantxa Chief Medical Officer | Option exercise · Restricted Stock Units | −41,534 | 83,066 | ||
| 2024-01-31 | Horga Maria Arantxa Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +192,800 | 192,800 | ||
| 2024-01-31 | Foster Wayne EVP, Chief Accounting Officer | Option exercise | +33,334 | 33,334 | ||
| 2024-01-31 | Foster Wayne EVP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −33,334 | 66,666 | ||
| 2024-01-31 | Foster Wayne EVP, Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +120,100 | 120,100 | ||
| 2024-01-31 | Vavricka John Chief Commercial Officer | Option exercise | +33,334 | 33,334 | ||
| 2024-01-31 | Vavricka John Chief Commercial Officer | Option exercise · Restricted Stock Units | −33,334 | 66,666 | ||
| 2024-01-31 | Vavricka John Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +132,800 | 132,800 |
Page 9 of 14 · 280 trades